Mark Genovese

Mark Genovese

Corporate Officer/Principal en ELI LILLY AND COMPANY .
Health Technology
Consumer Services

Perfil

Mark Genovese is currently the Senior Vice President-Immunology Development at Eli Lilly & Co. He previously worked as the Director at Kyverna Therapeutics, Inc. and as the Clinical Chief-Immunology & Rheumatology at Stanford University.
From 2020 to 2023, he served as the Senior Vice President-Inflammation Development at Gilead Sciences, Inc. Dr. Genovese completed his undergraduate degree at the University of Notre Dame and obtained his doctorate from The Johns Hopkins University School of Medicine.

Cargos activos de Mark Genovese

EmpresasCargoInicio
ELI LILLY AND COMPANY Corporate Officer/Principal 16/10/2023

Antiguos cargos conocidos de Mark Genovese.

EmpresasCargoFin
GILEAD SCIENCES, INC. Corporate Officer/Principal 01/09/2023
KYVERNA THERAPEUTICS, INC. Director/Miembro de la Junta -
Corporate Officer/Principal -
Ver el detalle de la experiencia de Mark Genovese.

Formación de Mark Genovese.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

21

Relaciones de 1er grado

6

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas6

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology